The humoral immune response to influenza vaccination in lung transplant patients

Mazzone P.J., Mossad S.B., Mawhorter S.D., Mehta A.C., Schilz R.J., Maurer J.R.

Source: Eur Respir J 2001; 18: 971-976
Journal Issue: December
Disease area: Respiratory infections

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mazzone P.J., Mossad S.B., Mawhorter S.D., Mehta A.C., Schilz R.J., Maurer J.R.. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 2001; 18: 971-976

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is influenza trivalent vaccination effective in lung transplant recipients?
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018



Pneumococcal and influenza vaccination
Source: Respipedia Article
Year: 2018

Prime-boost, double-dose immunization and immunity to influenza vaccination in COPD
Source: Virtual Congress 2021 – Pneumonia
Year: 2021


Influenza vaccination after lung transplantation: does nasal application improve immunological response?
Source: Eur Respir J 2001; 18: Suppl. 33, 179s
Year: 2001

Antibody response to influenza vaccine in patients with sarcoidosis
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010


Humoral immune response to influenza vaccination in silicosis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 695s
Year: 2006

Influenza: vaccination and treatment
Source: Eur Respir J 2001; 17: 1282-1293
Year: 2001



Pneumococcal vaccination in interstitial lung disease patients receiving systemic immunosuppressive treatment
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis  
Year: 2017

T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006

Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers
Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI
Year: 2005


Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine
Source: Eur Respir J 2002; 20: 813-818
Year: 2002



2009 pandemic influenza A (H1N1) in lung transplant recipients
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Assessment of humoral and cell-mediated immune response to measles mumps rubella vaccine viruses among patients with asthma
Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases
Year: 2010

A single season surveillance study of respiratory viral infections in lung transplant recipients
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007


Cytomegalovirus-specific cell-mediated immunity after prophylaxis predicts late-onset infection in lung transplantation
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020


Airway cellular response to two different immunosuppressive regimens in lung transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 466s
Year: 2004

Infectious complications after lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193
Year: 2003

A single-season prospective study of respiratory viral infections in lung transplant recipients
Source: Eur Respir J 2006; 28: 131-137
Year: 2006



Assessment of the association between asthma and immune responses to measles and mumps vaccine viruses
Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Year: 2008